Nipro
Nipro Corporation manufactures medical devices, pharmaceuticals and instrument products.
Launch date
Employees
Market cap
€1.5b
Enterprise valuation
€5.3b (Public information from Sep 2024)
Share price
JPY1367.5 8086.T
Osaka Osaka Prefecture (HQ)
Financials
Estimates*
JPY | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 455.6b | 494.8b | 545.2b | 586.8b | 635.8b | 668.3b | 700.7b |
% growth | 3 % | 9 % | 10 % | 8 % | 8 % | 5 % | 5 % |
EBITDA | 72.9b | 77.9b | 68.6b | 84.9b | 93.4b | 99.8b | 106.1b |
% EBITDA margin | 16 % | 16 % | 13 % | 14 % | 15 % | 15 % | 15 % |
Profit | 14.2b | 13.5b | 4.6b | 11.1b | 16.5b | 17.7b | 19.6b |
% profit margin | 3 % | 3 % | 1 % | 2 % | 3 % | 3 % | 3 % |
EV / revenue | 1.5x | 1.3x | 1.2x | 1.2x | 1.2x | 1.1x | 1.1x |
EV / EBITDA | 9.1x | 8.2x | 9.8x | 8.6x | 7.9x | 7.4x | 7.0x |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
Total Funding | - |
Related Content
Recent News about Nipro
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.